A Single Dose of ACE-011 Is Associated with Increases in Bone Formation and Decreases in Bone Resorption Markers in Healthy, Postmenopausal Women
Phase of Trial: Phase I
Latest Information Update: 01 Apr 2009
At a glance
- Drugs Sotatercept; Sotatercept
- Indications Postmenopausal osteoporosis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Acceleron Pharma
- 01 Apr 2009 Results have been reported in the British Journal of Clinical Pharmacology.
- 19 Dec 2008 Results published in the Journal of Bone and Mineral Research.
- 19 Sep 2007 Postive results have been reported.